𝔖 Bobbio Scriptorium
✦   LIBER   ✦

ERK and p38 MAP kinase activation are components of opioid-induced delayed cardioprotection

✍ Scribed by Ryan M. Fryer; Anna K. Hsu; Garrett J. Gross

Publisher
Springer
Year
2001
Tongue
English
Weight
298 KB
Volume
96
Category
Article
ISSN
0300-8428

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

ERK1/2 and p38 MAP kinases control prion
ERK1/2 and p38 MAP kinases control prion protein fragment 90–231-induced astrocyte proliferation and microglia activation
✍ Stefano Thellung; Valentina Villa; Alessandro Corsaro; Francesca Pellistri; Vale πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 516 KB

## Abstract Astrogliosis and microglial activation are a common feature during prion diseases, causing the release of chemoattractant and proinflammatory factors as well as reactive free radicals, involved in neuronal degeneration. The recombinant protease‐resistant domain of the prion protein (PrP

Inhibition of the p38 pathway upregulate
Inhibition of the p38 pathway upregulates macrophage JNK and ERK activities, and the ERK, JNK, and p38 MAP kinase pathways are reprogrammed during differentiation of the murine myeloid M1 cell line
✍ J. Perry Hall; Roger J. Davis πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 456 KB

Mitogen-activated protein (MAP) kinases have been implicated as important mediators of the inflammatory response. Here we report that c-Jun NH(2)-terminal kinase (JNK), extracellular signal-regulated kinase (ERK), and p38 MAP kinase activities are reprogrammed during the IL-6 induced macrophage-like